Teva Pharmaceutical CEO says health-care is facing 'huge disruption'
Teva and MedinCell Announce Positive Results for Registration Trial of Investigational Extended-Release Subcutaneous Injectable Risperidone for Patients with Schizophrenia | Business Wire
Teva Pharmaceuticals is found liable in the opioid crisis : NPR